Ayana T. Ruffin

772 total citations · 2 hit papers
12 papers, 479 citations indexed

About

Ayana T. Ruffin is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Ayana T. Ruffin has authored 12 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Immunology and 2 papers in Surgery. Recurrent topics in Ayana T. Ruffin's work include Cancer Immunotherapy and Biomarkers (9 papers), Immune Cell Function and Interaction (4 papers) and CAR-T cell therapy research (3 papers). Ayana T. Ruffin is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Immune Cell Function and Interaction (4 papers) and CAR-T cell therapy research (3 papers). Ayana T. Ruffin collaborates with scholars based in United States, France and Germany. Ayana T. Ruffin's co-authors include Tullia C. Bruno, Robert L. Ferris, Dan P. Zandberg, Lazar Vujanović, Sheryl Kunning, Umamaheswar Duvvuri, Dario A.A. Vignali, Lan Coffman, Seungwon Kim and Huda I. Atiya and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Nature reviews. Cancer.

In The Last Decade

Ayana T. Ruffin

11 papers receiving 476 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma

2021 230 citations Ayana T. Ruffin, Anthony R. Cillo et al. Nature Communications profile →
Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment

2022 175 citations Ayana T. Ruffin, Lazar Vujanović et al. Nature reviews. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ayana T. Ruffin United States	5	292	234	133	82	75	12	479
Sheryl Kunning United States	7	344 1.2×	305 1.3×	108 0.8×	71 0.9×	57 0.8×	10	503
Michael S. Leibowitz United States	10	315 1.1×	262 1.1×	166 1.2×	106 1.3×	40 0.5×	14	505
Huda I. Atiya United States	8	258 0.9×	202 0.9×	175 1.3×	61 0.7×	114 1.5×	11	491
Lillian Sun United States	7	378 1.3×	298 1.3×	120 0.9×	63 0.8×	36 0.5×	9	508
Anna Maria Wirsing Norway	8	230 0.8×	234 1.0×	83 0.6×	40 0.5×	44 0.6×	12	366
Jonathan H. Law United States	6	230 0.8×	97 0.4×	184 1.4×	65 0.8×	95 1.3×	7	439
Angen Liu United States	4	448 1.5×	421 1.8×	292 2.2×	98 1.2×	179 2.4×	5	776
Sarah Greene United States	5	370 1.3×	393 1.7×	81 0.6×	40 0.5×	36 0.5×	5	516
Irina Abécassis United States	6	186 0.6×	154 0.7×	147 1.1×	41 0.5×	80 1.1×	7	371
Yvonne Deuse Germany	5	154 0.5×	88 0.4×	136 1.0×	81 1.0×	60 0.8×	7	371

Countries citing papers authored by Ayana T. Ruffin

Since Specialization

Citations

This map shows the geographic impact of Ayana T. Ruffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayana T. Ruffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayana T. Ruffin more than expected).

Fields of papers citing papers by Ayana T. Ruffin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayana T. Ruffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayana T. Ruffin. The network helps show where Ayana T. Ruffin may publish in the future.

Co-authorship network of co-authors of Ayana T. Ruffin

This figure shows the co-authorship network connecting the top 25 collaborators of Ayana T. Ruffin. A scholar is included among the top collaborators of Ayana T. Ruffin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayana T. Ruffin. Ayana T. Ruffin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Greene, Emily R., Natalie K. Horvat, Deon B. Doxie, et al.. (2025). High-Dimensional Protein Analysis Uncovers Distinct Immunological and Stromal Features in Primary and Metastatic Pancreatic Ductal Adenocarcinoma. Cancer Research.

Ruffin, Ayana T., Sheryl Kunning, Anjali Rohatgi, et al.. (2025). Dysfunctional CD11c ⁻ CD21 ⁻ extrafollicular memory B cells are enriched in the periphery and tumors of patients with cancer. Science Translational Medicine. 17(786). eadh1315–eadh1315. 4 indexed citations

Knochelmann, Hannah M., Megan M. Wyatt, Natalie K. Horvat, et al.. (2025). Adoptively transferred Th17 cells cooperate with host B cells to achieve durable tumor immunity. Cancer Cell. 43(9). 1697–1713.e8. 1 indexed citations

Robinson, Brian, Alyssa M. Krasinskas, Natalie K. Horvat, et al.. (2025). Tumor site influences efficacy of MEKi and immunotherapy combinations in a preclinical model of cholangiocarcinoma. Hepatology. 2 indexed citations

Kunning, Sheryl, Huda I. Atiya, Ayana T. Ruffin, et al.. (2024). The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions. Cancer Cell. 42(11). 1864–1881.e5. 24 indexed citations

Ruffin, Ayana T., et al.. (2024). IL15 and IL21: Better When Membrane-Tethered Together on Antitumor T Cells. Clinical Cancer Research. 30(8). 1431–1433. 3 indexed citations

Ruffin, Ayana T., Brian M. Olson, Crystal Mallow, et al.. (2023). 629 Neoadjuvant SEMA4D inhibitor pepinemab combination with nivolumab increases crosstalk between B cell and CD26^hi T cell in patients with resectable stage III melanoma. SHILAP Revista de lepidopterología. A718–A718. 1 indexed citations

Ferris, Robert L., Jessica Moskovitz, Sheryl Kunning, et al.. (2022). Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer. Clinical Cancer Research. 28(7). 1335–1344. 25 indexed citations

Ruffin, Ayana T., et al.. (2022). Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment. Nature reviews. Cancer. 23(3). 173–188. 175 indexed citations breakdown →

10.

Ruffin, Ayana T., Anthony R. Cillo, Tracy Tabib, et al.. (2021). B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma. Nature Communications. 12(1). 3349–3349. 230 indexed citations breakdown →

11.

Dhupar, Rajeev, Olugbenga T. Okusanya, Seth Eisenberg, et al.. (2020). Characteristics of Malignant Pleural Effusion Resident CD8+ T Cells from a Heterogeneous Collection of Tumors. International Journal of Molecular Sciences. 21(17). 6178–6178. 13 indexed citations

12.

Bruno, Tullia C., Ayana T. Ruffin, Anthony R. Cillo, et al.. (2019). Tumor infiltrating B cells co-localize with CD4 T effector cells within organized tertiary lymphoid structures to present antigen and educate the anti-tumor immune response in human primary tumors. The Journal of Immunology. 202(1_Supplement). 138.15–138.15. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact